Prognosis of Patients With Stage D1 Prostatic Adenocarcinoma-Reference-Cited by-同舟云学术

Prognosis of Patients With Stage D1 Prostatic Adenocarcinoma

Published:1981-06 Issue:6 Volume:125 Page:817-819
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

Kramer Stephen A.¹,Cline Wayne A.¹,Farnham Robert¹,Carson Culley C.¹,Cox Edwin B.¹,Hinshaw Wanda¹,Paulson David P.¹

Affiliation:

1. From the Departments of Surgery, Medicine and Pathology, Duke University Medical Center and Veterans Administration Medical Center, Durham, North Carolina

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference20 articles.

1. The clinical spectrum of prostate cancer;de Vere White;J. Urol.,1977

2. The case for radical perineal prostatectomy;Jewett;J. Urol.,1970

3. An evaluation of endocrine therapy plus radical perineal prostatectomy in the treatment of advanced carcinoma of the prostate;Scott;J. Urol.,1964

4. Radical prostatectomy for carcinoma of the prostate: 1951-1976. A review of 329 patients;Boxer;J. Urol.,1977

5. Radical prostatectomy for carcinoma: 30-year experience and 15-year survivals;Hodges;J. Urol.,1979

Cited by 129 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sentinel node evaluation in prostate cancer;Clinical & Experimental Metastasis;2018-08

2. Impact of Lymph Node Burden on Survival of High-risk Prostate Cancer Patients Following Radical Prostatectomy and Pelvic Lymph Node Dissection;Frontiers in Surgery;2016-12-16

3. Long-term Outcomes Following Radiation Therapy For Prostate Cancer Patients With Lymph Node Metastases at Diagnosis Treated With and Without Surgery;American Journal of Clinical Oncology;2016-04

4. Utility of Choline Positron Emission Tomography/Computed Tomography for Lymph Node Involvement Identification in Intermediate- to High-risk Prostate Cancer: A Systematic Literature Review and Meta-analysis;European Urology;2013-06

5. Lymph node-positive prostate cancer: current issues, emerging technology and impact on clinical outcome;Expert Review of Anticancer Therapy;2011-09